Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEOLAR: Neoadjuvant Chemotherapy vs Standard Treatment for Rectal Cancer
NCT03280407Phase 2Unknown
- Sponsor
- Zealand University Hospital
- Start
- Mar 2017
- Primary completion
- Dec 2018
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, fluorouracil, capecitabine, folinic acid in rectal cancer, sponsored by Zealand University Hospital. Status: unknown.
02
Drugs
oxaliplatinfluorouracilcapecitabinefolinic acid
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT03280407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03280407.